Zobrazeno 1 - 10
of 892
pro vyhledávání: '"Interventional oncology [UMCN 1.5]"'
Autor:
Boyle, P., Robertson, C., Mazzetta, C., Keech, M., Hobbs, R., Fourcade, R., Kiemeney, L.A.L.M., Lee, C.
Publikováno v:
BJU International, 92, 575-80
BJU International, 92, 6, pp. 575-80
BJU International, 92, 6, pp. 575-80
Item does not contain fulltext OBJECTIVES: To assess the hypothesis that as lower urinary tract symptoms (LUTS) increase in severity, the impact as measured by the BPH impact index (BII) would also increase. SUBJECTS AND METHODS: The UREPIK survey co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e2ec50d353dfc5e64090978be010ee3f
https://ora.ox.ac.uk/objects/uuid:77b0914a-6ab5-4a11-b9b8-c967b2624e56
https://ora.ox.ac.uk/objects/uuid:77b0914a-6ab5-4a11-b9b8-c967b2624e56
Autor:
R.V. van Calck, T.G. van Tienen, R. G. J. C. Heijkants, J.H. de Groot, Arend Jan Schouten, Albert J. Pennings, Pieter Buma, René P. H. Veth
Publikováno v:
Journal of Biomedical Materials Research Part A, 87, 4, pp. 921-32
Journal of Biomedical Materials Research Part A, 87, 921-32
Journal of Biomedical Materials Research. Part A, 87A(4), 921-932. Wiley
Journal of Biomedical Materials Research Part A, 87, 921-32
Journal of Biomedical Materials Research. Part A, 87A(4), 921-932. Wiley
Contains fulltext : 71440.pdf (Publisher’s version ) (Closed access) Porous scaffolds have been made from two polyurethanes based on thermally induced phase separation of polymer dissolved in a DMSO/water mixture in combination with salt leaching.
Autor:
Marlies E. W. J. Peters, Marieke F.M. Gielissen, Constans A.H.H.V.M. Verhagen, Gijs Bleijenberg, Martine M. Goedendorp
Publikováno v:
Psycho-Oncology, 17, 1, pp. S34-S34
Psycho-Oncology, 17, S34-S34
British Journal of Cancer, 99, 1408-14
British Journal of Cancer
British Journal of Cancer, 99, 9, pp. 1408-14
Psycho-Oncology, 17, S34-S34
British Journal of Cancer, 99, 1408-14
British Journal of Cancer
British Journal of Cancer, 99, 9, pp. 1408-14
Contains fulltext : 71053.pdf (Publisher’s version ) (Closed access) It is generally known that fatigue is a common symptom during cancer treatment, and in cancer survivors. However, fatigue was never studied after diagnosis, before cancer treatmen
Autor:
Martine Piccart, Robert Paridaens, Patrick Therasse, Jan Bogaerts, David Cameron, M. Nooij, Luc Dirix, Tanja Cufer, Louk V.A.M. Beex
Publikováno v:
Journal of Clinical Oncology, 26, 30, pp. 4883-90
Journal of Clinical Oncology, 26, 4883-90
Paridaens, R J, Dirix, L Y, Beex, L V, Nooij, M, Cameron, D A, Cufer, T, Piccart, M J, Bogaerts, J & Therasse, P 2008, ' Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group ', Journal of Clinical Oncology, vol. 26, no. 30, pp. 4883-90 . https://doi.org/10.1200/JCO.2007.14.4659
Journal of Clinical Oncology, 26, 4883-90
Paridaens, R J, Dirix, L Y, Beex, L V, Nooij, M, Cameron, D A, Cufer, T, Piccart, M J, Bogaerts, J & Therasse, P 2008, ' Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group ', Journal of Clinical Oncology, vol. 26, no. 30, pp. 4883-90 . https://doi.org/10.1200/JCO.2007.14.4659
Purpose This phase III randomized open-label clinical trial was designed to evaluate the efficacy and safety of the steroidal aromatase inactivator exemestane versus the antiestrogen tamoxifen as first-line treatment for metastatic breast cancer (MBC
Autor:
Miep A. van der Drift, Daphne M. Snik, Ad F.T.M. Verhagen, Monique A H Steegers, Oliver H.G. Wilder-Smith
Publikováno v:
Journal of Pain, 9, 955-61
Journal of Pain, 9(10), 955-61. Churchill Livingstone
Journal of Pain, 9, 10, pp. 955-61
Steegers, M A H, Snik, D M, Verhagen, A F, van der Drift, M A & Wilder-Smith, O H G 2008, ' Only half of the chronic pain after thoracic surgery shows a neuropathic component ', Journal of Pain, vol. 9, no. 10, pp. 955-61 . https://doi.org/10.1016/j.jpain.2008.05.009
Journal of Pain, 9(10), 955-61. Churchill Livingstone
Journal of Pain, 9, 10, pp. 955-61
Steegers, M A H, Snik, D M, Verhagen, A F, van der Drift, M A & Wilder-Smith, O H G 2008, ' Only half of the chronic pain after thoracic surgery shows a neuropathic component ', Journal of Pain, vol. 9, no. 10, pp. 955-61 . https://doi.org/10.1016/j.jpain.2008.05.009
Contains fulltext : 71376.pdf (Publisher’s version ) (Closed access) Chronic pain is a common complication after thoracic surgery. The cause of chronic post-thoracotomy pain is often suggested to be intercostal nerve damage. Thus chronic pain after
Autor:
Raj Persad, Hideyuki Akaza, Roger Buckley, Marc Colombel, Andreas Böhle, Mark S. Soloway, Joan Palou, Donald L. Lamm, J. Alfred Witjes, Maurizio Brausi
Publikováno v:
European Urology Supplements, 7, 637-50
European Urology Supplements, 7, 10, pp. 637-50
European Urology Supplements, 7, 10, pp. 637-50
Context The guidelines of the European Association of Urology (EAU), the First International Consultation on Bladder Tumors (FICBT), the National Comprehensive Cancer Network (NCCN), and the American Urological Association (AUA) all provide an excell
Autor:
J. Alfred Witjes, Prasad S Kolli
Publikováno v:
Expert Opinion on Investigational Drugs, 17, 7, pp. 1085-96
Expert Opinion on Investigational Drugs, 17, 1085-96
Expert Opinion on Investigational Drugs, 17, 1085-96
Item does not contain fulltext OBJECTIVE: To describe clinical needs in non-muscle invasive bladder cancer (NMIBC) and review the potential of apaziquone in this respect. METHODS: Epidemiology and clinical practice in NMIBC, as well as new drugs and
Autor:
Otto C. Boerman, Wouter V. Vogel, Wim J.G. Oyen, Theo J.M. Ruers, Thamar H. Stollman, Marian G.W. Scheer
Publikováno v:
The Journal of Nuclear Medicine (1978), 50, 168-168
The Journal of Nuclear Medicine (1978), 49, 6, pp. 887-91
The Journal of Nuclear Medicine (1978), 50, 1, pp. 168-168
The Journal of Nuclear Medicine (1978), 49, 887-91
The Journal of Nuclear Medicine (1978), 49, 6, pp. 887-91
The Journal of Nuclear Medicine (1978), 50, 1, pp. 168-168
The Journal of Nuclear Medicine (1978), 49, 887-91
Contains fulltext : 80240.pdf (Publisher’s version ) (Closed access) In murine models, resection of a primary tumor leads to increased vascularization and accelerated growth of metastases that previously had remained microscopic. To study such a po
Autor:
Jan J.M. Kums, Wim P.J. Witjes, Maria H.D. Janzing-Pastors, Marcel J.F.M. de Bruin, J. Alfred Witjes, Kees Hendricksen, Christien Caris, Jan G. Idema, Oncko B. van Vierssen Trip, Henk Vergunst
Publikováno v:
European Urology, 53, 984-91
European Urology, 53, 5, pp. 984-91
European Urology, 53, 5, pp. 984-91
Contains fulltext : 71191.pdf (Publisher’s version ) (Closed access) OBJECTIVES: To study the additive effect of either an early instillation or maintenance instillations of adjuvant intravesical epirubicin, as compared to the epirubicin "standard"
Autor:
Robert Huddart, Johannes Classen, Roberto Salvioni, Rainer Souchon, Walter Albrecht, Xavier Garcia del Muro, Malcolm David Mason, Michael Bamberg, Johnathan Joffe, Jutta Scheiderbauer, Annette Dieing, Oscar Leiva Galvis, Niels E. Skakkebæk, Ronald de Wit, William G. Jones, Sophie D. Fosså, Kai Uwe Koehrmann, H. G. Derigs, Silke Gillessen, Martin Fenner, Sergei Tjulandin, C Clemm, Wolfgang Hoeltl, Padraig Warde, Aude Flechon, Luis Paz Ares, Pieter H.M. De Mulder, S. Kliesch, Nicola Nicolai, Thomas Powles, László Kisbenedek, Lothar Weissbach, Craig R. Nichols, Hans von der Maase, Michael Jewett, Jörg Pont, Markus A. Kuczyk, Volker Loy, Christian Wittekind, Peter Albers, Jose Ramon Germa-Lluch, Felix Sedlmayer, Giovanni Rosti, D. Ondruš, Pilar Laguna, Heinz Schmidberger, István Bodrogi, Gabriella Cohn-Cedermark, Eva Cavallin-Ståhl, Jörg Beyer, Tim Oliver, Arthur Gerl, Gedske Daugaard, Stefan Weinknecht, Tobias Pottek, Hans-Joachim Schmoll, Maike de Wit, Rolf Mueller, Maria De Santis, Michael Hartmann, Graham M. Mead, Oliver Rick, Jean Pierre Droz, Christian K. Kollmannsberger, Hans U. Schmelz, Karim Fizazi, Gosse O N Oosterhof, Lori Wood, Thomas Gauler, Aslam Sohaib, Susanne Krege, Ferran Algaba, Alan Horwich, Eva Winter, Stéphane Culine, Giorgio Pizzocaro, Olbjørn Klepp, Axel Heidenreich, Klaus Peter Dieckmann, Jörg T. Hartmann, Mark Schrader, Lajos Géczi, Carsten Bokemeyer
Publikováno v:
European Urology
European Urology, Elsevier, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 3, pp. 497-513
European Urology, 53, 478-496
European Urology, 53, 3, pp. 478-496
European Urology, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 497-513
European Urology, 53(3), 478-496. Elsevier
European Urology, 53(3), 497-513. Elsevier
European Urology, Elsevier, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 3, pp. 497-513
European Urology, 53, 478-496
European Urology, 53, 3, pp. 478-496
European Urology, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 497-513
European Urology, 53(3), 478-496. Elsevier
European Urology, 53(3), 497-513. Elsevier
Objectives: The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the